---
title: "INKON Life: Acquisition of Changsha Kexin completed the industrial and commercial change registration"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/242603396.md"
description: "On May 30th, INKON Life announced that the transaction for the 51% equity stake in Changsha Kexin Oncology Hospital Co., Ltd., which was previously acquired for RMB 357 million in cash, has completed the industrial and commercial change registration procedures. This means that Changsha Kexin officially becomes a subsidiary of INKON Life and is included in the company's consolidated financial statements"
datetime: "2025-05-30T13:32:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/242603396.md)
  - [en](https://longbridge.com/en/news/242603396.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/242603396.md)
generator: "portal-rs"
---

# INKON Life: Acquisition of Changsha Kexin completed the industrial and commercial change registration

On May 30th, INKON Life announced that the transaction for the acquisition of 51% equity in Changsha Kexin Oncology Hospital Co., Ltd. for RMB 357 million in cash has completed the industrial and commercial change registration procedures. This means that Changsha Kexin has officially become a subsidiary controlled by INKON Life and is included in the company's consolidated financial statements

### Related Stocks

- [300143.CN](https://longbridge.com/en/quote/300143.CN.md)

## Related News & Research

- [OpenAI's ad business shows blistering growth, hits $1 billion annualized revenue run rate](https://longbridge.com/en/news/297522913.md)
- [10:12 ETOnymos and Vanta Diagnostics Collaborate to Scale Intelligent Lab Intake](https://longbridge.com/en/news/297799488.md)
- [ChatGPT Health adds Epic integration for clinicians to import patient data](https://longbridge.com/en/news/297680881.md)
- [Spider AF Report Reveals $25.3B Global First Half Ad Fraud Losses](https://longbridge.com/en/news/297796253.md)
- [Teqnion agrees to acquire Scotland-based Abercromby Vending](https://longbridge.com/en/news/297759475.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**